A reader asked me to look at the results they just got back. I was pleasantly surprise to see some significant improvements in their report
Lactobacillus and Bifidobacterium is now reported
This is a classic CFS profile!
Akkermansia is cleanly reported
Again, a classic CFS result. See this post on Increasing Akkermansia I did earlier.
Rare Bacteria are listed simply
Checking a few other uBiome results that I could access, we did find a strong pattern for three. And an over representation (25% of the CFS samples versus 13% of general samples)
- Thermonaerobacterales 2/8
- Gelria: 2/8
- Synergistaceae: 2/7
- Low Akkermansia 6/8
- Low Lactobacillus 8/8
- Low Bifidobaceria 7/8
One reader was very rich in rare results:
Three groups appear to be very common as low to non-existent
- Akkermansia 75%
- Lactobacillus 100%
- Bifidobaceria 87%
There is work going on in getting an Akkemansia probiotic approved for sale. Remember to avoid most lactobacillus because it will push out bifidobacteria… instead, focus on only bifidobacteria probiotics.
Another new set of reports have been added, as shown below. This is done using data derived from the KEGG Pathway Database,
Each of these can expand, for example:
We see two items of interest, ALA (alpha-linolenic acid metabolism) is low and Arachidonic acid metabolism is high. See ALA article and Arachidonic acid metabolism: role in inflammation (1991)
- So, taking ALA supplements would be strongly suggested
Spot checking other ubiome results, I saw one reader had
- D-arginine and D-ornithine metabolism being a very low 0.09x
- Flavonoid biosynthesis a low 0.27x
Again, this hits at specific supplements in lieu of gut bacteria doing their jobs.
Bottom Line 2
The ubiome results give much more friendly data and at a low cost. If you are unsure that you have CFS/IBS/FM, then comparing your results to the above may answer the question. Of greater interest is the additional tables of what part of the KEGG pathway may suggest supplementation.